Leading policy-makers and scholars explain how market forces, deregulation, and consumer choice can work to improve health care for all Americans.


Innovative drugs cost patients less in the long run
Kerri Houston, Chicago Sun-Times, 7-31-04

Carping about the cost of pharmaceuticals misses the real question: what is their value to patients and society?

Project FDA.
home   spotlight   commentary   research   events   news   about   contact   links   archives
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000